Works matching IS 15747891 AND DT 2023 AND VI 17 AND IP 3
Results: 13
Targeting protein folding in N‐Myc‐driven medulloblastoma.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 3, p. 387, doi. 10.1002/1878-0261.13395
- By:
- Publication type:
- Article
IL‐7 germline variant: setting the stage for immune‐related adverse events.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 3, p. 384, doi. 10.1002/1878-0261.13392
- By:
- Publication type:
- Article
More may not be better: reconsidering early clinical trial design in the era of targeted cancer therapeutics.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 3, p. 382, doi. 10.1002/1878-0261.13391
- By:
- Publication type:
- Article
Data sharing and management in 21st century cancer research.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 3, p. 381, doi. 10.1002/1878-0261.13385
- By:
- Publication type:
- Article
Overexpression of synaptic vesicle protein Rab GTPase 3C promotes vesicular exocytosis and drug resistance in colorectal cancer cells.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 3, p. 422, doi. 10.1002/1878-0261.13378
- By:
- Publication type:
- Article
Integrative characterisation of secreted factors involved in intercellular communication between prostate epithelial or cancer cells and fibroblasts.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 3, p. 469, doi. 10.1002/1878-0261.13376
- By:
- Publication type:
- Article
LINC00173 facilitates tumor progression by stimulating RAB1B‐mediated PA2G4 and SDF4 secretion in nasopharyngeal carcinoma.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 3, p. 518, doi. 10.1002/1878-0261.13375
- By:
- Publication type:
- Article
Building predictive disease models using extracellular vesicle microscale flow cytometry and machine learning.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 3, p. 407, doi. 10.1002/1878-0261.13362
- By:
- Publication type:
- Article
Expression pattern of secretory‐cell‐related transcriptional signatures in colon adenocarcinomas defines tumor microenvironment characteristics and correlates with clinical outcomes.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 3, p. 499, doi. 10.1002/1878-0261.13338
- By:
- Publication type:
- Article
Atezolizumab and stereotactic body radiotherapy in patients with advanced non‐small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT‐1 trial.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 3, p. 487, doi. 10.1002/1878-0261.13330
- By:
- Publication type:
- Article
Post‐prostatic‐massage urine exosomes of men with chronic prostatitis/chronic pelvic pain syndrome carry prostate‐cancer‐typical microRNAs and activate proto‐oncogenes.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 3, p. 445, doi. 10.1002/1878-0261.13329
- By:
- Publication type:
- Article
Cancer as an infective disease: the role of EVs in tumorigenesis.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 3, p. 390, doi. 10.1002/1878-0261.13316
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 3, p. 379, doi. 10.1002/1878-0261.13233
- Publication type:
- Article